News Releases & Statements
News Releases & Statements
LLS Urges Blood Cancer Patients to get Vaccinated as its National Patient Registry Enters Next Phase in COVID-19 Vaccine Studies
Posted On: July 15, 2021Rye Brook, N.Y., July 15, 2021—The Leukemia & Lymphoma Society® (LLS) began recruitment this week for a new study evaluating T-cell immune response to COVID-19 vaccine among people with a current or past diagnosis of blood cancer. This invitation-only follow-up study will include a sub-set of participants from a larger LLS study examining COVID-19 spike antibody response to vaccination. Read More
Philanthropic Powerhouses Remain Laser-Focused in Pursuit of a World without Cancer
Posted On: July 14, 2021 Read More
Relentless High School Students Forge Ahead for a Future Without Cancer
Posted On: June 30, 2021 Read More
FDA Approves a Targeted Treatment for a Rare Form of Blood Cancer
Posted On: June 21, 2021 Read More
34 Patient Groups: Preservation of protections is an important win — but critical work remains
Posted On: June 17, 2021WASHINGTON, D.C, June 17, 2021 – 34 patient organizations representing millions of people living with serious and chronic health conditions issued the following statement regarding the Supreme Court’s ruling upholding the Affordable Care Act:
Read More
Subaru of America Dedicates June to Sharing Hope and Warmth with Those Battling Cancer
Posted On: June 1, 2021 Read More
The Leukemia & Lymphoma Society launches Impact Research grants to help underserved patients access to clinical trials
Posted On: May 6, 2021Collaborations with Mayo Clinic, Vanderbilt University Medical Center and Weill Cornell Medicine will Increase Representation of Geographically, Ethnically and Economically Underserved Communities in Clinical Trials.
Read MoreMedia Requests
Please send all media-related inquiries and interview requests to mediarelations@lls.org. An LLS representative will respond as soon as possible.